Mi-Co E-Forms Software for Clinical Trials Data Collection Covers 44th Annual DIA Conference
RESEARCH TRIANGLE PARK , NC . August 4, 2008 – Mi-Co, (www.mi-corporation.com), the mobile data collection software provider, showed its E-Form solutions in clinical trials applications and exhibited the recent release of Mi-Forms Version 7 at the 44th Annual Drug Information Association (DIA) Conference.
Mi-Co was present in its own booth, shared with partner, Optiform, a provider of automated healthcare data collection solutions, and the booths of Anoto, the developer of digital pen technology, and Dell.
Mi-Forms E-Forms software solutions for field data collection have been validated for compliance with FDA Regulation 21 CFR Part 11 . Mi-Forms customers save time, improve efficiency, increase the quality of data and improve access to that data by automating paper data collection processes. Mi-Forms’ unique, paper-like user interface allows full electronic data capture including source data, while providing field users a comfortable, natural, pen-based style of input requiring minimal training. Highly flexible Mi-Forms software runs on mobile devices such as laptop and tablet PCs, digital pens, pocket PCs and signature capture pads, and can be integrated with existing CTMS and EDC systems.
Mi-Forms can be used in clinical trials applications such as eCRFs, site monitoring visit reports, pen-based EDC, ePRO, SAE reporting and direct eSource generation, all of which significantly improve data entry processes at sites and ensure better quality and availability of data. Clinical trials companies can receive a free E-Forms Assessment from Mi-Co and read white papers, comparative technology studies, and user application articles at the Mi-Co site.
Mi-Co currently has many clinical trials customers, with solutions deployed by CROs, government and academic labs, and medical device manufacturers. “With our powerful data collection capability and experience with 21 CFR Part 11 validation, Mi-Forms is perfectly suited for use in clinical trials,” explained Mi-Co Chief Executive Officer, Dr. Greg Clary. “DIA allowed us to showcase the new features of Mi-Forms Version 7, and through conversations with industry leaders, it was clear that our product fills critical electronic forms needs in clinical trials.”
Mi-Co is the developer of market-leading mobile data collection and process automation software products and solutions. Mi-Co’s flagship product, Mi-Forms, provides powerful and flexible E-Form design, mobile data capture, real-time data validation, and central administration of users, forms and data. Mi-Co’s unique technology includes 4 patents issued and 7 patents pending in digital ink and mobile data capture technology. Key Mi-Forms benefits include improved efficiency, increased effectiveness, and better availability related to mobile data collection, validation and management processes. With the easiest, most user-friendly interface and highly flexible solution creation and deployment, Mi-Co is changing the way people conduct mobile data collection tasks. Mi-Co is headquartered in Research Triangle Park, NC, with a customer service center in Seattle. For more information on Mi-Co, visit www.mi-corporation.com.